APMRS 2025

under the motto:

Functional Proteomics and Metabolomics

The Austrian Proteomics and Metabolomics Association (APMA) and TU Wien are hosting the next Austrian Proteomic and Metabolomic Research Symposium APMRS 2025 from the 12th13th of September 2025. Join us in September for two days of thrilling MS-based science at the beautiful central location of the TUtheSky, offering one of the best views of the Vienna city!

Venue

TU Wien – TUtheSky

Getreidemarkt 9

1060 Vienna

Austria

Registration

APMRS 2025 is free of charge for APMA members

Non-APMA members: 50 €

Deadline for abstract submission: 30th of June 2025

Deadline for registration: 31st of August 2025

Topics:

  • Functional proteomics: activity-based proteomics, PTM proteomics, structural proteomics, drug (off) target elucidation;
  • Resolving metabolic pathways: Stable isotope resolved metabolomics, lipidomics;
  • Special applications in medicine and biotechnology: Clinical proteomics and metabolomics, metaproteomics, host cell omics;
  • Multiomics, bioinformatics, novel toolsand many more!

Invited speakers:

Christopher Chang, Princeton University

Chris Chang studied at the California Institute of Technology and earned his B.S. and M.S. degrees in chemistry in 1997, after which he worked in the laboratory of Jean-Pierre Sauvage at the Université Louis Pasteur as a Fulbright Fellow. In 1998, he moved to the Massachusetts Institute of Technology as a NSF/Merck Graduate Fellow. During his doctoral studies, Chris worked in the laboratory of Daniel G. Nocera. After earning his PhD in inorganic chemistry in 2002, Chris remained at MIT, working with Stephen J. Lippard as a Jane Coffin Childs Fellow. He currently holds the position of Professor of Bioorganic Chemistry at Princeton. The main focus of his work is activity-based sensing as a general platform to identify transition metals, reactive oxygen species, and one-carbon units as new classes of single-atom signals for allosteric regulation of protein function.

Matej Orešič, University of Turku

(SFB Lipid hydrolysis invited lecture)

Matej Orešič holds a PhD in Biophysics from Cornell University. He is Professor of Medicine with Specialization in Systems Medicine at Örebro University (Sweden) and Group Leader in Systems Medicine at Turku Bioscience Centre (Finland). As of 2016, he was made a Lifetime Honorary Fellow of the Metabolomics Society. He is one of the founders of the Nordic Metabolomics Society and currently its Chair of the Board. Dr. Orešič currently also serves in the Board of Directors of the Metabolomics Society. Prof. Orešič’s main research areas include metabolomics applications in biomedical research and systems medicine. He is particularly interested in the identification of disease processes, with a central focus on both type 1 diabetes and non-alcoholic fatty liver disease. Prof. Orešič also initiated the popular MZmine open-source project.

Ilaria Piazza, Max Delbrück Center for Molecular Medicine

Ilaria did her PhD studies at EMBL in Heidelberg, where she embarked on a project studying the molecular machines regulating chromatin structure and gene expression during the cell cycle using yeast genetics, cell and structural biology. During her PhD, Ilaria started her venture into crosslinking mass spectrometry in the Beck laboratory. This brought her to study protein structures with a -omics perspective in at ETH Zurich and later at Biognosys. Her current research goal as a group leader at MDC Berlin is to study how metabolism regulates chromatin architecture and its impact on gene expression using proteomics, genomics and metabolomics.

We are looking forward to see you all in Vienna in September!